摘要
应用XM6逆转录病毒载体将人IL-2cDNA转入小鼠B16黑色素瘤细胞。丝裂霉素C处理的转染前后B16细胞作为瘤苗对小鼠进行免疫接种。结果显示，接种B16-IL-2细胞可明显排斥再移植黑色素瘤的生长。对脾淋巴细胞检测的结果表明，MLTR引起的淋巴细胞增殖与特异性CTL杀伤活性，以及NK、LAK活性与诱生的IL-2水平几项指标，B16-IL-2细胞免疫组均明显高于B16免疫组及对照组。提示转基因肿瘤细胞在体内分泌IL-2增强了机体的特异性与非特异性免疫功能。
IL-2 was introduced into mice B16 melanoma cell line by using retrovlrus infection method. Both B16 and B16-IL-2 cells were treated with Mit C beforehand and were then inoculated intraperitoneally as vaccines in mice respectively. Hanks solution was used instead of the vaccine in the control group. The data showed that the tumor incidence rate was zero in the group receiving B16-IL-2 vaccine followed by B16 inoculation. However, incidence rate was 100% in both the B16 vaccine immunization group and in the control groups. Experiments also indicated that the prollferation of splenic lymphocytcs induced by MLTR, the specific cytotoxicity of CTL against B16 cells, the activities of splenic NK, LAK, and the level of IL-2 secretion in mice immunlzed by B16-IL-2 were much higher than those in the mice immunized only with B16 cells as well as the controls. These data indicated that secretion of IL-2 in mice promoted specific and nonspecific anti-tumor immunity of mice. The theoretic basis was provided for IL-2-secreting tumor vaccine.
出处
《中国医学科学院学报》
CAS
CSCD
北大核心
1997年第1期60-63,共4页
Acta Academiae Medicinae Sinicae
